Pharmabiz2h
Caliway’s drug molecule CBL-514 to treat Dercum’s disease receives EMA orphan drug designation
Caliway Biopharmaceuticals (Caliway), a Taiwan-headquartered, clinical-stage biopharmaceutical company driven to breakthrough drug discovery of novel small-molecule therapeutics, has announced that ...
Pharmabiz2h
Biocon Academy achieves 100% placement for its 6th batch and concludes 5th edition of MCADDI residential programme for industry
Biocon Academy announced a 100% placement success for Batch 6 of the Biocon Ramaiah Certificate Programme in Quality Control Analytical, achieved in a record 2.5 hours. The placement drive attracted ...
Pharmabiz3h
GSK-sponsored survey reveals unique gaps in care and support facing patients with gynaecologic cancers
GSK plc announced the results of a GSK-sponsored multinational survey designed to raise awareness of challenges that people with gynaecologic cancers may experience. The survey, which was conducted by ...
Pharmabiz6h
Eupraxia Pharma reports positive data from RESOLVE phase 1b/2a trial of EP-104GI for treatment of eosinophilic esophagitis
Victoria, British Columbia Thursday, November 14, 2024, 18:00 Hrs [IST] ...
Pharmabiz7h
AstraZeneca India and Indian Academy of Paediatrics Unite to raise awareness on respiratory syncytial virus in India
AstraZeneca India and Indian Academy of Paediatrics Unite to raise awareness on respiratory syncytial virus in India: Our Bureau, Bengaluru Thursday, November 14, 2024, 16:45 Hrs ...
Pharmabiz6h
CPHI & PMEC India to showcase innovation & sustainability
As a significant milestone in India's pharma sector, the 17th edition of CPHI & PMEC India, organised by Informa Markets in India, returns in an advanced format, scheduled from November 26 to 28, 2024 ...
Pharmabiz6h
Survey shows unsustainable regulatory workloads leave no choice about AI adoption
Survey shows unsustainable regulatory workloads leave no choice about AI adoption: Boston, Massachusetts Thursday, November 14, 2024, 17:00 Hrs [IST] ArisGlobal, an innovative tec ...
Pharmabiz13h
Ginkgo Bioworks advances collaboration with Merck to improve biologics manufacturing; Ginkgo to receive a research milestone payment of $9 million
Ginkgo Bioworks advances collaboration with Merck to improve biologics manufacturing; Ginkgo to receive a research milestone payment of $9 million: Boston, Massachusetts Thursday, ...
Pharmabiz8h
IDF research reveals diabetes impacts the mental well-being of over 4 in 5 Indians living with the condition
IDF research reveals diabetes impacts the mental well-being of over 4 in 5 Indians living with the condition: Our Bureau, Bengaluru Thursday, November 14, 2024, 15:45 Hrs [IST] In ...
Pharmabiz15h
Health Canada approves GSK’s Ojjaara for the treatment of myelofibrosis in adults who have moderate to severe anaemia
Mississauga, Ontario Thursday, November 14, 2024, 09:00 Hrs [IST] ...
Pharmabiz12h
Islamic Development Bank joins efforts with WHO and development partners to promote health impact investment
Islamic Development Bank joins efforts with WHO and development partners to promote health impact investment: Geneva Thursday, November 14, 2024, 12:00 Hrs [IST] As part of its co ...
Pharmabiz14h
Qiagen collaborates with McGill University to advance microbiome research
Qiagen collaborates with McGill University to advance microbiome research: Montreal, Canada Thursday, November 14, 2024, 10:00 Hrs [IST] Qiagen, a Netherlands-based leading global ...